用了200多年的地高辛,你竟然还不会?赶紧来“恶补”!( 八 )

因此 , 在应用地高辛中 , 我们不仅仅需要监测血药浓度 , 更需要关注患者相应的临床表现 , 以期提前发现其不良反应 。

地高辛在临床实践中应用已有长期的历史和丰富的经验 , 我们仍相信地高辛若能被合理使用 , 依然应该是心力衰竭和房颤治疗的重要药物之一 。

参考文献:

[1]Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J et al: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2016, 18(11):1609-1678.

[2]Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA et al: 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European journal of heart failure 2016, 18(8):891-975.